If upregulation of SNAIL or downregulation of VDR in tumours could be monitored by RT–PCR analysis of circulating RNA levels, this would constitute a valuable tool for the selection of candidates for therapy with vitamin D analogues. The gene discussed is SNAI1; the disease is neoplasm.